Comparative Pharmacology
Head-to-head clinical analysis: MULTIHANCE versus MULTIHANCE MULTIPACK.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MULTIHANCE versus MULTIHANCE MULTIPACK.
MULTIHANCE vs MULTIHANCE MULTIPACK
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Gadobenate dimeglumine is a paramagnetic contrast agent that increases signal intensity in magnetic resonance imaging (MRI) by shortening T1 relaxation times in tissues where it accumulates, primarily due its gadolinium content.
Gadobenate dimeglumine is a paramagnetic contrast agent that enhances magnetic resonance imaging by increasing the relaxation rate of water protons in tissues where it accumulates. The gadolinium ion (Gd3+) shortens T1 and T2 relaxation times, leading to increased signal intensity on T1-weighted images.
0.1 mmol/kg (0.2 mL/kg) IV as a single bolus injection; maximum dose 0.3 mmol/kg (0.6 mL/kg) for CNS imaging.
0.1 mmol/kg body weight (0.2 mL/kg) intravenous bolus injection; maximum single dose 0.3 mmol/kg (0.6 mL/kg)
None Documented
None Documented
Terminal elimination half-life: 2.0 hours in patients with normal renal function (creatinine clearance >60 mL/min); prolonged to up to 30 hours in end-stage renal disease
Terminal elimination half-life: 1.5–2.2 hours in patients with normal renal function; prolonged (up to 30 hours) in severe renal impairment (eGFR <30 mL/min/1.73m²)
Renal: 95-100% (glomerular filtration) within 72 hours; fecal: <0.1%
Renal excretion: 95% unchanged drug via glomerular filtration; biliary/fecal: <0.1%
Category C
Category C
MRI Contrast Agent
MRI Contrast Agent